The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Read more about The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
Targeting HER proteins in cancer therapy and the role of the non-target HER3. Read more about Targeting HER proteins in cancer therapy and the role of the non-target HER3.
Mechanisms of adverse effects of anti-VEGF therapy for cancer. Read more about Mechanisms of adverse effects of anti-VEGF therapy for cancer.
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Read more about STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines.
Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer. Read more about Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer.
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Read more about Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.
The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials. Read more about The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials.
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. Read more about Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Read more about Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.
Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Read more about Daycare attendance and risk of childhood acute lymphoblastic leukaemia.
